Navigation Links
First Quarter 2008 Financial Results Announcement and Teleconference
Date:4/16/2008

PHILADELPHIA, April 16 /PRNewswire-FirstCall/ -- On Wednesday, April 23, 2008, GlaxoSmithKline plc will announce its first quarter financial results for the three months ended March 31, 2008. The announcement is scheduled to be released to the London Stock Exchange at approximately 7:00 am (ET) US and will be available on the website: http://www.gsk.com shortly thereafter.

Following the announcement, JP Garnier, Chief Executive Officer and Julian Heslop, Chief Financial Officer, will hold a global teleconference for analysts and investors. You are invited to listen in to this presentation of the first quarter 2008 results. This teleconference will take place on:

Wednesday, April 23rd at 9:00 am ET

To participate in the teleconference please dial:

U.S. Toll Free Phone +1 877 491 0064

Please quote: GSK Q1 Results

A recording of the teleconference will be available from 1:00 pm ET on April 23rd (until April 30th) on:

U.S. Toll Free phone + 1 888 365 0240

Passcode: 792110

GSK will host a live audio webcast of the results presentation with synchronized slides. It will begin at the same time as the teleconference, 9:00 am ET, and can be accessed directly via the GlaxoSmithKline website: http://gsk.com. Slides will be available shortly before the teleconference on the GSK website.

An archived version of this webcast will be available from the corporate website at approximately 3:00 pm ET on the same day.


'/>"/>
SOURCE GlaxoSmithKline plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
3. Kewaunee Scientific Announces First Quarter Results and Quarterly Dividend
4. Genmab Announces 2007 First Half Year Results
5. Pharsight Achieves First License Sale for Public-Source Database
6. Novare Announces First Ever Single Port Laparoscopic Kidney Removal (Nephrectomy) Using RealHand(TM) HD Instruments
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. China Medical Technologies Reports First Quarter Financial Results
9. Pressure BioSciences, Inc. Issued First Patent in Canada
10. Peregrine Pharmaceuticals to Announce First Quarter FY 2008 Financial Results
11. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... ... 10, 2017 , ... USDM Life Sciences , the ... sciences and healthcare industries, announces a presentation by Subbu Viswanathan and Jennifer Jaye ... GxP Validation for Agile Cloud Platforms,” will present a revolutionary approach to achieving ...
(Date:10/9/2017)... ... , ... At its national board meeting in North Carolina, ARCS® Foundation ... of Physics and Astronomy, has been selected for membership in ARCS Alumni Hall ... 2015 Breakthrough Prize in Fundamental physics for the discovery of the accelerating expansion of ...
(Date:10/7/2017)... (PRWEB) , ... October 06, ... ... leader in Hi-C-based genomic technologies, launched its ProxiMeta™ Hi-C metagenome deconvolution product, ... Hi-C kit and accompanying cloud-based bioinformatics software to perform Hi-C metagenome deconvolution ...
(Date:10/5/2017)... (PRWEB) , ... October 05, 2017 , ... LabRoots ... and scientists from around the world, is giving back to cancer research with a ... October. , Now through October 31, shoppers can use promo code PinkRibbon to ...
Breaking Biology Technology:
(Date:4/11/2017)... -- NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" ... of independent Directors Mr. Robin D. Richards and ... furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer ... guidance and benefiting from their considerable expertise as we move ...
(Date:4/5/2017)... 2017 Today HYPR Corp. , leading ... component of the HYPR platform is officially FIDO® ... security architecture that empowers biometric authentication across Fortune 500 ... secured over 15 million users across the financial services ... home product suites and physical access represent a growing ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
Breaking Biology News(10 mins):